The natural history and osteodystrophy of mucolipidosis types II and III

Journal of Paediatrics and Child Health

Volumn 46, Issue 6, 2010, Pages 316-322

  David Vizcarra, Grace ^a   Briody, Julie ^b   Ault, Jenny ^a   Fietz, Michael ^d   Fletcher, Janice ^d   Savarirayan, Ravi ^e   Wilson, Meredith ^a   McGill, Jim ^f   Edwards, Matthew ^a   Munns, Craig ^a   Alcausin, Melanie ^a   Cathey, Sara ^g   Sillence, David ^a,c  

^a Department of Clinical Genetics ^*  (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g GREENWOOD GENETIC CENTER   (United States)

Author keywords

'pseudohyperparathyroidism'; hyperparathyroidism; mucolipidosis; osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; OSTEOCALCIN;

ARTICLE; BONE DENSITOMETRY; BONE METABOLISM; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CREATININE URINE LEVEL; DISEASE COURSE; FEMALE; HUMAN; HYPERPARATHYROIDISM; MALE; MORBIDITY; MUCOLIPIDOSIS TYPE 2; MUCOLIPIDOSIS TYPE 3; OSTEODYSTROPHY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MUCOLIPIDOSES; NEW ZEALAND; RENAL OSTEODYSTROPHY; YOUNG ADULT;

EID: 77953847708     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01715.x     Document Type: Article

References (37)

1. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999 281: 249 254.
2. Kornfeld S, Sly WS. I-Cell Disease and Pseudo-Hurler Polydystrophy: Disorders of Lysosomal Enzyme Phosphorylation and Localization, 8th edn.
3. Cathey SS, Kudo M, Tiede S et al. Molecular order in mucolipidosis II and III nomenclature. Am. J. Med. Genet. A 2008 146A: 512 513.
4. Sly W, Sundaram V. The I-Cell model: the molecular basis for abnormal lysosomal enzyme transport in mucolipidosis II and mucolipidosis III. In: Lloyd JK, ed. Genetic and Metabolic Diseases in Pediatrics.
5. Leroy JDM, Optiz J. I-cell disease. Birth Defects Orig. Artic. Ser. 1969 5: 174 187.
6. Okada S, Owada M, Sakiyama T, Yutaka T, Ogawa M. I-cell disease: clinical studies of 21 Japanese cases. Clin. Genet. 1985 28: 207 215.
7. Maroteaux P, Lamy M. La pseudopolydystrophie de Hurler. Presse Med. 1966 74: 2889 2895.
8. Kelly TE, Thomas GH, Taylor HA et al. Mucolipidosis III (pseudo-Hurler polydystrophy): clinical and laboratory studies in a series of 12 patients. Johns Hopkins Med. J. 1975 137: 156 175.
9. Poenaru L, Castelnau L, Tome F, Boue J, Maroteaux P. A variant of mucolipidosis. II. Clinical, biochemical and pathological investigations. Eur. J. Pediatr. 1988 147: 321 327.
10. Kozlowski K, Lipson A, Carey W. Mild I-cell disease, or severe pseudo-Hurler polydystrophy in three siblings: further evidence for intermediate forms of mucolipidosis II and III. Radiological features. Radiol. Med. (Torino) 1991 82: 847 851.
11. Honey NK, Mueller OT, Little LE, Miller AL, Shows TB. Mucolipidosis III is genetically heterogeneous. Proc. Natl. Acad. Sci. U.S.A. 1982 79: 7420 7424.
12. Shows TB, Mueller OT, Honey NK, Wright CE, Miller AL. Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants. Am. J. Med. Genet. 1982 12: 343 353.
13. Mueller OT, Honey NK, Little LE, Miller AL, Shows TB. Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis. J. Clin. Invest. 1983 72: 1016 1023.
14. Little LE, Mueller OT, Honey NK, Shows TB, Miller AL. Heterogeneity of N-acetylglucosamine 1-phosphotransferase within mucolipidosis III. J. Biol. Chem. 1986 261: 733 738.
15. Bao M, Elmendorf BJ, Booth JL, Drake RR, Canfield WM. Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1- phosphotransferase. II. Enzymatic characterization and identification of the catalytic subunit. J. Biol. Chem. 1996 271: 31446 31451.
16. Raas-Rothschild A, Cormier-Daire V, Bao M et al. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC). J. Clin. Invest. 2000 105: 673 681.
17. Tiede S, Storch S, Lubke T et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat. Med. 2005 11: 1109 1112.
18. Sillence DO. Bone Dysplasia. Genetic and Ultrastructural Aspects with Reference to Osteogenesis Imperfecta.
19. Pazzaglia UE, Beluffi G, Bianchi E, Castello A, Coci A, Marchi A. Study of the bone pathology in early mucolipidosis II (I-cell disease). Eur. J. Pediatr. 1989 148: 553 557.
20. Unger S, Paul DA, Nino MC et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. Eur. J. Pediatr. 2005 164: 236 243.
21. Pazzaglia UE, Beluffi G, Campbell JB et al. Mucolipidosis II: correlation between radiological features and histopathology of the bones. Pediatr. Radiol. 1989 19: 406 413.
22. Haley SM, Coster WJ, Ludlow LH, Haltiwanger JT, Andrellow PJ. Pediatric Evaluation of Disability Inventory (PEDI) Version 1.0: Development, Standardization and Administration Manual.
23. Cathey SS, Leroy JG, Wood T et al. Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J. Med. Genet. 2010 47: 38 48.
24. Spranger J. Bone dysplasia 'families'. Pathol. Immunopathol. Res. 1988 7: 76 80.
25. Babcock DS, Bove KE, Hug G, Dignan PS, Soukup S, Warren NS. Fetal mucolipidosis II (I-cell disease): radiologic and pathologic correlation. Pediatr. Radiol. 1986 16: 32 9.
26. Leroy JG, Spranger JW, Feingold M, Opitz JM, Crocker AC. I-cell disease: a clinical picture. J. Pediatr. 1971 79: 360 365.
27. Maroteaux P, Hors-Cayla MC, Pont J. Type II mucolipidosis. Presse Med. 1970 78: 179 181.
28. Patriquin HB, Kaplan P, Kind HP, Giedion A. Neonatal mucolipidosis II (I-cell disease): clinical and radiologic features in three cases. Am. J. Roentgenol. 1977 129: 37 43.
29. Cipolloni C, Boldrini A, Donti E, Maiorana A, Coppa GV. Neonatal mucolipidosis II (I-cell disease): clinical, radiological and biochemical studies in a case. Helv. Paediatr. Acta 1980 35: 85 95.
30. Whelan DT, Chang PL, Cockshott PW. Mucolipidosis II. The clinical, radiological and biochemical features in three cases. Clin. Genet. 1983 24: 90 6.
31. Taber P, Gyepes MT, Philippart M, Ling S. Roentgenographic manifestations of Leroy's I-cell disease. Am. J. Roentgenol. Radium. Ther. Nucl. Med. 1973 118: 213 221.
32. Pazzaglia UE, Beluffi G, Danesino C, Frediani PV, Pagani G, Zatti G. Neonatal mucolipidosis 2. The spontaneous evolution of early bone lesions and the effect of vitamin D treatment. Report of two cases. Pediatr. Radiol. 1989 20: 80 4.
33. Pazzaglia UE, Beluffi G, Castello A, Coci A, Zatti G. Bone changes of mucolipidosis II at different ages. Postmortem study of three cases. Clin. Orthop. Relat. Res. 1992 276: 283 290.
34. Marx SJ, Lasker RD, Brown EM et al. Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1986 62: 445 449.
35. Robinson C, Baker N, Noble J et al. The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment. J. Inherit. Metab. Dis. 2002 25: 681 693.
36. Hubler M, Haskins ME, Arnold S et al. Mucolipidosis type II in a domestic shorthair cat. J. Small Anim. Pract. 1996 37: 435 441.
37. Bosshard NU, Hubler M, Arnold S et al. Spontaneous mucolipidosis in a cat: an animal model of human I-cell disease. Vet. Pathol. 1996 33: 1 13.